Compare EQH & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | RVTY |
|---|---|---|
| Founded | 1859 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.8B |
| IPO Year | N/A | 1994 |
| Metric | EQH | RVTY |
|---|---|---|
| Price | $44.22 | $100.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | $63.00 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 2.8M | 1.5M |
| Earning Date | 01-01-0001 | 04-26-2026 |
| Dividend Yield | ★ 2.44% | 0.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $43.47 | $6.34 |
| Revenue Next Year | $7.61 | $5.10 |
| P/E Ratio | ★ N/A | $82.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $41.39 | $81.36 |
| 52 Week High | $56.61 | $120.39 |
| Indicator | EQH | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 44.29 |
| Support Level | $43.01 | $93.94 |
| Resistance Level | $45.82 | $100.04 |
| Average True Range (ATR) | 1.68 | 4.09 |
| MACD | -0.03 | -0.77 |
| Stochastic Oscillator | 30.17 | 36.50 |
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.